Immune thrombocytopenic purpura: Difference between revisions

From Libre Pathology
Jump to navigation Jump to search
Michael (talk | contribs)
Michael (talk | contribs)
more
Line 1: Line 1:
{{ Infobox diagnosis
| Name      = {{PAGENAME}}
| Image      =
| Width      =
| Caption    =
| Synonyms  = immune thrombocytopenia
| Micro      = germinal centres in white pulp (~55% of cases), [[neutrophil]]s in the red pulp (~67% of cases), macrophages in the red pulp
| Subtypes  = clinical: primary, secondary
| LMDDx      =
| Stains    =
| IHC        =
| EM        =
| Molecular  =
| IF        =
| Gross      = +/-prominent white nodules (spleen), normal appearance (most common)
| Grossing  =
| Site      = systemic - see ''[[spleen]]''
| Assdx      =
| Syndromes  =
| Clinicalhx =
| Signs      =
| Symptoms  = bleeding
| Prevalence = uncommon
| Bloodwork  = thrombocytopenia, antiplatelet antibodies
| Rads      =
| Endoscopy  =
| Prognosis  = dependent on underlying cause
| Other      =
| ClinDDx    =
| Tx        = corticosteroids, possibly splenectomy
}}
'''Immune thrombocytopenic purpura''', abbreviated '''ITP''', is a rare condition.  
'''Immune thrombocytopenic purpura''', abbreviated '''ITP''', is a rare condition.  



Revision as of 03:53, 6 May 2014

Immune thrombocytopenic purpura
Diagnosis in short

Synonyms immune thrombocytopenia

LM germinal centres in white pulp (~55% of cases), neutrophils in the red pulp (~67% of cases), macrophages in the red pulp
Subtypes clinical: primary, secondary
Gross +/-prominent white nodules (spleen), normal appearance (most common)
Site systemic - see spleen

Symptoms bleeding
Prevalence uncommon
Blood work thrombocytopenia, antiplatelet antibodies
Prognosis dependent on underlying cause
Treatment corticosteroids, possibly splenectomy

Immune thrombocytopenic purpura, abbreviated ITP, is a rare condition.

General

Presentation:

  • Bleeding - usually.[1]

Blood work:

  • Thrombocytopenia.
  • Antiplatelet antibodies.

Treatment:

  • Usually treated with corticosteroids.[1]
    • Possibly retuximab.[2]
  • Refractory cases get a splenectomy.

Prevalence:

  • Uncommon.

Classification

Gross

Features:[5]

  • Typically ~ 100 grams.
  • +/-Prominent white nodules (AKA Malpighian corpuscles) - uncommon.

Microscopic

Features:[5]

  • Germinal centres in white pulp (~55% of cases)
    • Classically described as "proliferative".
  • Neutrophils in the red pulp (~67% of cases).
  • Macrophages in the red pulp (~25% of cases). †

Notes:

  • Changes not dependent on titre of antiplatelet antibodies.[5]
  • † May be a finding associated with treatment.[5]
  • The classic changes are proliferation of lymphoid germinal centres and red pulp PMNs.

Images

See also

References

  1. ↑ 1.0 1.1 Kistangari G, McCrae KR (June 2013). "Immune thrombocytopenia". Hematol. Oncol. Clin. North Am. 27 (3): 495–520. doi:10.1016/j.hoc.2013.03.001. PMID 23714309.
  2. ↑ Zhang, C.; Liu, HF.; Chen, XH.; Gao, L.; Gao, L.; Liu, Y.; Kong, PY.; Sun, AH. et al. (Mar 2014). "Is splenectomy necessary for immune thrombocytopenic purpura? The role of rituximab in patients with corticosteroid resistance in a single-center experience.". Clin Ther 36 (3): 385-8. doi:10.1016/j.clinthera.2014.01.017. PMID 24594069.
  3. ↑ Cines DB, Liebman H, Stasi R (January 2009). "Pathobiology of secondary immune thrombocytopenia". Semin. Hematol. 46 (1 Suppl 2): S2–14. doi:10.1053/j.seminhematol.2008.12.005. PMC 2682438. PMID 19245930. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2682438/.
  4. ↑ Kuwana M (January 2014). "Helicobacter pylori-associated immune thrombocytopenia: clinical features and pathogenic mechanisms". World J. Gastroenterol. 20 (3): 714–23. doi:10.3748/wjg.v20.i3.714. PMC 3921481. PMID 24574745. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3921481/.
  5. ↑ 5.0 5.1 5.2 5.3 Hayes MM, Jacobs P, Wood L, Dent DM (September 1985). "Splenic pathology in immune thrombocytopenia". J. Clin. Pathol. 38 (9): 985–8. PMC 499346. PMID 4044880. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC499346/.